We also invite you to take a close look at the IAS 2023 logo. It is inspired by the art of Leah Cummins, a Mayi-kulan woman from north-western Queensland, which celebrates the gathering of many people from many places in Meeanjin Brisbane, the home of the Yuggera people.
Please be aware that session recordings will be available on the virtual platform 24 hours after the session finishes.
Coming up today
09:00 AEST
Today’s plenary session, “Vaccines and cure: Spotlight on antibodies”, is moderated by former IAS President Linda-Gail Bekker from the Desmond Tutu Health Foundation, South Africa. Wilton Bryan William from the Duke University School of Medicine, United States, presents “Engineered HIV-1 immunogens to induce bNab responses”, and Katharine Bar from the Penn Centre for AIDS Research, US, presents “Strategies for using antibodies for HIV cure”. The plenary concludes with the awarding of the JIAS Impact Award.
10:30 AEST
The Co-Chair’s Choice session includes abstract presentations on a social network-based intervention in Kenya that increased HIV self-testing and linkage to health facilities among fishermen and results from a double-blind Phase 3 trial that compares once-daily doravirine/islatravir and bictegravir/emtricitabine/tenofovir alafenamide as initial HIV-1 treatment.
The symposium, “Social science and HIV in the fifth decade”, looks back at 40 years of social science research on HIV and the role it will play now that several breakthroughs in biomedical research have transformed the landscape.
“Long-acting technologies: A game changer?”, is moderated by Carl Dieffenbach from the DHHS/NIH/NIAID. Claudia Cortes from Universidad de Chile presents “New antiretrovirals and HIV treatment strategies” and Cissy Kityo Mutuluuza from the Joint Clinical Research Centre in Uganda presents “Long-acting treatment in adolescents”.
14:45 AEST
Gain insight into how the words we use and the angle of stories we tell have shaped the evolution of the HIV pandemic at the symposium, “Getting the story and telling it right: HIV in the media”. A panel of top journalists will discuss lessons learnt from over 40 years of reporting on HIV.
Today’s second plenary, “Communities leading the way: Combining approaches to community engagement”, includes presentations by James Ward from the University of Queensland (“Empowering First Nations communities to combat BBVs and STIs”) and Virginia Macdonald from WHO (“Social network approaches to HIV testing”). It concludes with the awarding of the IAS Me and My Healthcare Provider awards.
18:30 AEST
The day rounds off with a range of satellite sessions. Among them is “Evolving clinical perspectives in HIV”, organized by MSD. It will focus on challenges, perspectives and unmet needs in HIV treatment and management.
Yesterday
23 July recap
The response of the host country has been comprehensive and inclusive with impressive results, IAS 2023 Local Chair Charles Gilks told delegates at the opening session. And this can be attributed to the collaborative efforts of researchers, healthcare professionals, community organizations and advocates. Australia, he said, was now on the brink of achieving a monumental milestone – the elimination of HIV transmission.
Other highlights from yesterday included:
Prevention: People living with HIV who have an undetectable viral load using any World Health Organization (WHO) prequalified combination of sample and testing platform, including dried blood spot samples, and continue taking medication as prescribed have “zero risk” of transmitting HIV to their sexual partner(s), WHO revealed in a policy brief. For more information and what you need to know, click here.
U=U: With a focus on Asia and the Pacific, stakeholders explored opportunities and challenges in providing comprehensive HIV responses and accelerating progress towards ending AIDS as a public health threat. Vietnam signed the U=U Call to Action and revealed that over 86,000 people are on PrEP in the country through delivery methods that include one-stop shops, telemedicine, pharmacies and mobile services for those who cannot come to clinics.
Vertical transmission: Use of effective ART has significantly reduced the incidence of vertical transmission, but there are challenges and gaps in providing optimal care and treatment for pregnant and breastfeeding women and newborns, particularly in resource-limited settings. A session convened by the IAS Corporate Partnership Programme brought together stakeholders who discussed the obstacles to developing and implementing long-acting HIV prevention and treatment options.
The exhibition
Don’t miss the opportunity to talk directly with representatives from key organizations in the HIV response! If you haven’t already, explore the exhibition in Hall 1 Concourse, Foyer Level next to the Great Hall, as well as virtually.
The poster exhibition
You can explore the IAS 2023 poster exhibition on the Foyer Level next to the plenary hall, as well as virtually from wherever you are in the world. On site, the poster exhibition is open from 10:00 to 17:15 on Monday, 24 July. Presenters – representatives of key organizations in the HIV response – will be at their posters to answer questions from 12:00 to 13:00. Here’s a taste of what you can expect today:
JIAS supplement just launched
The JIAS special issue, “Person-centred approaches to address the health needs of people living with HIV and co-infections and co-morbidities", has been launched! This collection of articles spotlights the latest scientific evidence, best practices and community perspectives on person-centred care from Africa, North America and Europe. Read it for free and join the satellite session at 18:30 AEST today.
Rapporteur summaries
The rapporteur summaries are your primary source for the highlights presented at IAS 2023. Thanks to the IAS 2023 team of experts, delegates can access daily recaps by each programme track. The rapporteur summaries will be available by 22:00 AEST each day here.
In the news
Meet the IAS change makers
Each day, the Daily Digest follows the IAS change makers at IAS 2023: carefully selected HIV researchers, advocates, healthcare providers and others we educate to drive an evidence-based HIV response that puts people first.
Today’s change maker is Jakkrapatara Boonruang, a research physician affiliated with the Institute of HIV and Research Innovation in Bangkok, Thailand. His research focuses on HIV and STI prevention, screening and treatment, sexual health and gender-affirming hormone therapy for trans people.
He is at IAS 2023 with the Mark Wainberg Fellowship Programme. He is delivering two presentations on the topline findings from the HPTN 083 study and implications for Asia and a study on long-acting injectable ART for key populations in Thailand.
Snapshots from IAS 2023
Official media partner coverage
|
